Aakash Madhu

Aakash Madhu is a Managing Director at Linden Capital Partners, a Chicago-based private equity firm that is among the largest in the United States dedicated exclusively to healthcare investing. He has been involved in principal investing and investment banking since 2009, building deep expertise across the healthcare and life sciences landscape. He holds a Bachelor of Science in Economics with a concentration in Finance from The Wharton School at the University of Pennsylvania and a Bachelor of Arts in Mathematics from Penn's College of Arts & Sciences, both earned magna cum laude.

Madhu began his career in the healthcare investment banking group at Credit Suisse, where he developed foundational experience in healthcare deal execution and financial analysis. He subsequently joined Lindsay Goldberg, a private equity firm where he evaluated and executed investment opportunities across a broad range of industries. Prior to joining Linden, he co-founded 4YAY Medical Innovations, a medical device development company, and was involved in several other entrepreneurial ventures in the healthcare space, giving him both operator and investor perspectives.

At Linden Capital Partners, Madhu has contributed to the firm's growth as it has scaled to approximately $12.5 billion in regulatory assets under management, having invested in over 45 healthcare companies encompassing more than 350 total transactions. His dual background as an entrepreneur-operator and a trained investment banker brings a distinctive vantage point to sourcing and evaluating healthcare deals. In addition to his institutional private equity work, the original investor profile indicates he is also active as an angel investor at the seed stage.

Aakash Madhu's investment focus, shaped by his work at Linden Capital Partners, centers on healthcare and life sciences businesses with strong market positions in the middle market. The thesis at Linden rests on three pillars: (1) deep healthcare and life science industry specialization, (2) integrated private equity and operating expertise, and (3) strategic relationships with large corporations that can drive value creation. Linden targets leveraged buyouts across medical products, specialty distribution, pharmaceutical, and healthcare services segments. Madhu's entrepreneurial background in medical devices suggests a particular affinity for healthcare products and innovation-driven companies. His angel investing activity at the seed stage indicates an interest in early-stage healthcare opportunities beyond the firm's core buyout strategy.